Glycosylation and immunoreactivity of the Histoplasma capsulatum Cfp4 yeast-phase exoantigen

Area of Science:

• Mycology and Pathogenesis
• Fungal Immunology
• Molecular Biology

Background:

• Histoplasma capsulatum is a thermally dimorphic fungus, with its yeast phase being the virulent form.
• Culture filtrate protein 4 (Cfp4) is a secreted, glycosylated protein specific to Histoplasma yeast, implying a role in pathogenesis.

Purpose of the Study:

• To characterize the Histoplasma Cfp4 protein, including its glycosylation sites and epitopes.
• To investigate the role of Cfp4 in Histoplasma pathogenesis and virulence.
• To evaluate the diagnostic potential of Cfp4 as an exoantigen for histoplasmosis.

Main Methods:

• Generation of monoclonal antibodies against Cfp4 for characterization and epitope mapping.
• Site-directed mutagenesis to identify N-linked glycosylation sites on Cfp4.
• Construction of Cfp4-deficient Histoplasma strains using insertional mutagenesis and RNA interference.
• Virulence assays in human macrophages and a murine model of histoplasmosis.
• Coinfection experiments to assess Cfp4's contribution to fungal fitness.

Main Results:

• Three monoclonal antibodies were generated, and key N-linked glycosylation sites on Cfp4 were identified.
• Cfp4-deficient Histoplasma strains showed no attenuation in virulence in macrophages or mice.
• Cfp4 production did not confer a fitness advantage during murine lung infection.
• Cfp4 is consistently secreted by yeast cells across different phylogenetic groups and is recognized by human immune sera.

Conclusions:

• Cfp4 is not essential for the acute virulence of Histoplasma capsulatum in murine models.
• The conserved secretion and recognition of Cfp4 by human immune sera indicate its potential as a diagnostic marker for histoplasmosis.